MX1 - 2025 Appendix 4E and Annual Report
Filed with ASX · · 86 pages · English
Summary by 6ix AI
The report indicates a significant increase in net loss compared to the previous year, attributed to decreased revenues and the discontinuation of certain product lines. Despite the losses, the company has made strides in securing partnerships and advancing its medical imaging technologies, particularly with the Rover Plus mobile X-ray system. The report also highlights the company's commitment to innovation in healthcare imaging and its ongoing projects with major healthcare providers and government agencies.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
In the deck
Story so far
Earlier from Micro-X
- MX1 - Supply Agreement with Major US Healthcare Provider
- MX1 - Micro-X Achieves $2.3m of Development Milestones
- MX1 - Appendix 4C and Quarterly Activities Statement
- MX1 - Result of Entitlement Offer
- MX1 - December 2024 Half Year Results Presentation
Later from Micro-X
- MX1 - 2025 Full Year Results Presentation
- MX1 - $4.4M IGP Grant Received for Head CT
- MX1 - $2.5M Checkpoints Contract Extension with DHS
- MX1 - Head CT Milestone - Proceeding to Imaging Trial
- MX1 - $3.3M Rover Plus Order from Malaysian MOH
Follow Micro-X into a list and get an email when it puts out news.
Follow Micro-X